Admission glycemia and markers of inflammation are independent outcome predictors in primary PCI in non-diabetic patients

E. Corrada, A. Cappelleri, G. Belli, S. Genovese, C. Barbaro, G. Gasparini, P. Pagnotta, M. Rossi, D. Zavalloni, P. Presbitero

Research output: Contribution to journalArticle

Abstract

Aim. To assess the prognostic value of admission plasma glucose (APG) respect to clinical variables and inflammatory markers in a selected population of non-diabetic patients with ST elevation myocardial infarction (STEMI) treated with primary angioplasty (primary coronary intervention, PCI). Methods. A total of 188 consecutive non-diabetic STEMI patients undergoing primary PCI were divided into four quartiles based on APG (170 mg/dL). Combined end-point of major adverse cardiac events (MACE) was defined as death, acute heart failure, re-infarction, unstable angina or inducible ischemia. Results. Event-free survival from MACE was significantly (P170 mg/dL (hazard ratio [HR] 2.39, 95% confidence interval [CI] 1.24 to 4.65, P

Original languageEnglish
Pages (from-to)445-452
Number of pages8
JournalMinerva Cardioangiologica
Volume56
Issue number5
Publication statusPublished - Oct 2008

Keywords

  • Angioplasty, balloon, methods
  • C reative protein
  • Glucose, blood
  • Inflammation
  • Myocardial infarction
  • Prognosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Admission glycemia and markers of inflammation are independent outcome predictors in primary PCI in non-diabetic patients'. Together they form a unique fingerprint.

  • Cite this